To Test a New Drug (LCFA-01) for Safety and PK in Healthy Adults for Bacterial Vaginosis Infection.

Recruiting Phase 1 Interventional Study
Bacterial Vaginosis Treatment
Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 40
Sex
Female
Trial phase
Phase 1
Study type
Interventional
Purpose
Treatment
Participants needed
30 (estimated)
Sponsor
Massachusetts General Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study is being done to check how safe and comfortable LCFA-01 is when used inside the vagina. LCFA-01 is a natural product that contains oleic acid, and it comes as a soft gel capsule that participants will place in the vagina using their fingers. The main purpose of the study is to make sure the product is safe and does not cause any problems or discomfort. The study will also measure how m…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Females aged 18 to 40 years (inclusive) who are pre-menopausal at the time of providing informed consent * You should be generally healthy, with no major past illnesses, and your doctor should not see anything concerning during your check-up before starting the study. * Your B…
Contacts

Dr Douglas Kwon

+18572687160

dkwon@mgh.harvard.edu

CONTACT

Dr Caroline Mitchell, MD, MPH

+16177242182

caroline.mitchell@mgh.harvard.edu

CONTACT